These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3751581)

  • 1. A staphylococcal alpha-toxin fragment. Its characterization and use for mapping biologically-active regions of alpha-toxin.
    Blomqvist L; Thelestam M
    Acta Pathol Microbiol Immunol Scand B; 1986 Aug; 94(4):277-83. PubMed ID: 3751581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization of hemolytic and mouse lethal activities of C. perfringens alpha-toxin need simultaneous blockade of two epitopes by monoclonal antibodies.
    Schoepe H; Wieler LH; Bauerfeind R; Schlapp T; Potschka H; Hehnen HR; Baljer G
    Microb Pathog; 1997 Jul; 23(1):1-10. PubMed ID: 9250775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of alpha-toxin of Clostridium oedematiens type A.
    Izumi N; Kondo H; Ohishi I; Sakaguchi G
    Jpn J Med Sci Biol; 1983 Jun; 36(3):135-46. PubMed ID: 6632349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and some properties of a lethal toxic fragment of staphylococcal alpha-toxin by tryptic digestion.
    Watanabe M; Kato I
    Biochim Biophys Acta; 1978 Aug; 535(2):388-400. PubMed ID: 678558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isolation and characteristics of staphylococcal alpha-toxin].
    Noskov AN; Ezepchuk IuV
    Mol Gen Mikrobiol Virusol; 1985 Mar; (3):34-7. PubMed ID: 3842745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and some properties of staphylococcal alpha-toxin.
    Watanabe M; Kato I
    Jpn J Exp Med; 1974 Apr; 44(2):165-78. PubMed ID: 4546168
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of hemolytic and cytotoxic activity of staphylococcal alpha-toxin in vitro by incubation with cultured fibroblasts. Brief communication.
    Szmigielski S; Harshman S
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(3):297-301. PubMed ID: 664979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation and properties of the staphylococcal toxin causing the toxic shock syndrome].
    Fan'kovskaia MK; Ezepchuk IuV; Solov'eva MN; Shcheglovitova ON
    Mol Gen Mikrobiol Virusol; 1987 Jul; (7):23-7. PubMed ID: 3670320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lethal toxic fragment and receptor of staphylococcal alpha-toxin (author's transl)].
    Kato I
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():96-108. PubMed ID: 800283
    [No Abstract]   [Full Text] [Related]  

  • 10. [A simple method of purifying staphylococcal alpha-toxin and a study of its properties].
    Beĭlbaeva ML; Bukharova TB; Ezepchuk IuV
    Mol Gen Mikrobiol Virusol; 1991 Sep; (9):28-30. PubMed ID: 1745273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal toxicity of Shigella dysenteriae cytotoxin: evidence that the neurotoxic, enterotoxic, and cytotoxic activities are due to one toxin.
    Eiklid K; Olsnes S
    J Immunol; 1983 Jan; 130(1):380-4. PubMed ID: 6336624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antibodies to staphylococcal alpha and beta toxins and Staphylococcus aureus on the cytotoxicity for and adherence of the organism to bovine mammary epithelial cells.
    Cifrian E; Guidry AJ; O'Brien CN; Marquardi WW
    Am J Vet Res; 1996 Sep; 57(9):1308-11. PubMed ID: 8874724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropharmacological characterization of fragment B from tetanus toxin.
    Simpson LL; Hoch DH
    J Pharmacol Exp Ther; 1985 Jan; 232(1):223-7. PubMed ID: 3965693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human monoclonal antibody with the capacity to neutralize Staphylococcus aureus alpha-toxin.
    Heveker N; Hansen A; Hungerer KD; von Baehr R; Glaser RW
    Hum Antibodies Hybridomas; 1994; 5(1-2):18-24. PubMed ID: 7858179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and potency of cyclodextrin-lipid inhibitors of Staphylococcus aureus α-toxin.
    Weeks AC; Balzli CL; Caballero A; Tang A; O'Callaghan R
    Curr Eye Res; 2012 Feb; 37(2):87-93. PubMed ID: 22050601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of a novel Staphylococcus chromogenes exfoliative toxin.
    Sato H; Hirose K; Terauchi R; Abe S; Moromizato I; Kurokawa S; Maehara N
    J Vet Med B Infect Dis Vet Public Health; 2004 Apr; 51(3):116-22. PubMed ID: 15107037
    [No Abstract]   [Full Text] [Related]  

  • 17. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
    Kum WW; Laupland KB; Chow AW
    Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the beta-toxins from Staphylococcus aureus and Staphylococcus intermedius.
    Dziewanowska K; Edwards VM; Deringer JR; Bohach GA; Guerra DJ
    Arch Biochem Biophys; 1996 Nov; 335(1):102-8. PubMed ID: 8914839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited proteolysis of bovine alpha-lactalbumin: isolation and characterization of protein domains.
    Polverino de Laureto P; Scaramella E; Frigo M; Wondrich FG; De Filippis V; Zambonin M; Fontana A
    Protein Sci; 1999 Nov; 8(11):2290-303. PubMed ID: 10595532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related differences in rabbits during experimental Staphylococcus aureus keratitis.
    O'Callaghan RJ; McCormick CC; Caballero AR; Marquart ME; Gatlin HP; Fratkin JD
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5125-31. PubMed ID: 17962465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.